top of page
For most cost-effective consulting services:
Click here
Home
All News
Pharma
APAC
Brazil
Canada Pharma
China Pharma
Europe Pharma
India Pharma
Japan Pharma
North America
Saudi Arabia
US FDA Approvals
Therapy News
Immunology
Neurology
Oncology
Kidney Diseases
Cardiovascular
Infections_Vaccines
Metabolic Diseases
Women Health
Healthcare News
US Healthcare News
US Payer News
Europe Healthcare News
Germany Healthcare
Italy
United Kingdom Healthcare
APAC - Healthcare News
Brazil Healthcare
Healthcare Policies
Conferences
About
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
US_PayerNews
Radioligand therapy
NICE recommendations
Germany Healthcare Pharma News
HAS Assessment Outcomes
Neurology
Immunology
Blood Disorders
Oncology
Kidney Diseases
Cardiovascular Diseases
Infectious_Vaccines
Search
Roche's petrelintide showed benefits but early results show inferior benefits over Lilly's eloralintide | iPharmaCenter
Badari Andukuri
Mar 6
Roche’s GLP‑1/GIP receptor agonist CT‑388 demonstrated strong efficacy in patients with obesity | iPharmaCenter
ipharmaservices
Jan 27
Sun Pharma obtains DCGI nod to produce generic semaglutide injection for weight management in India | iPharmaCenter
Badari Andukuri
Jan 25
Aspect Biosystems Deepens Novo Nordisk Alliance to Advance Curative Cell Therapies for Diabetes | iPharmaCenter
ipharmaservices
Jan 21
Lilly Takes on Novo Nordisk with Head-to-Head Data Comparing Zepbound and Wegovy | iPharmaCenter
ipharmaservices
Dec 6, 2024
Tirzepatide significantly reduced the risk of progression to type 2 diabetes in adults with prediabetes and obesity, preventing most from developing the disease over 176 weeks | iPharmaCenter
ipharmaservices
Nov 14, 2024
Pfizer decides to continue development of GLP agonist Danuglipron | iPharmaCenter
ipharmaservices
Jul 16, 2024
Obesity News | Overweight | Treatments |Updates | iPharmaCenter
ipharmaservices
Aug 21, 2023
Diabetes mellitus News | iPharmaCenter
ipharmaservices
Mar 19, 2023
NASH News | Updates | Liver disease
ipharmaservices
May 30, 2022
bottom of page
